Can the GSK share price soar higher after hitting 17-year high?
The British drug maker wowed investors last month after upgrading its full-year earnings guidance following a strong third quarter performance that sent shares soaring, with analysts believing the stock could climb even higher.
Is the Aviva share price undervalued?
Despite the insurer’s share price losing more than 20% of its value over the last five years, the stock continues to pay decent dividends and analysts remain positive about its prospects over the medium-term.
A wave of high-profile listings are expected to hit the markets in 2020, but which of these stocks will dominate the IPO space? We take a look at the top UK, US and international IPO contenders for the months to come.